Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of Lipid Research|April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolismMargaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.
Journal of Lipid Research|May 29, 2007
Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolismStefania Lamon-Fava, Margaret R Diffenderfer, P Hugh R Barrett, et al.
Lipids|March 27, 2015
Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent MannerNgoc-Anh Le, Margaret R Diffenderfer, Nuntakorn Thongtang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2005
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 productionJohn S Millar, Cyrille Maugeais, Katsunori Ikewaki, et al.
Metabolism: Clinical and Experimental|March 1, 2005
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beingsJennifer L Jenner, Leo J Seman, John S Millar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteinsStefania Lamon-Fava, Margaret R Diffenderfer, P Hugh R Barrett, et al.
Journal of Lipid Research|April 18, 2003
Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humansBerthil H C M T Prinsen, Johannes A Romijn, Peter H Bisschop, et al.
Clinical Biochemistry|December 21, 2002
Idiopathic hypoalbuminemia explained by reduced synthesis rate and an increased catabolic rateBerthil H C M T Prinsen, George A Kaysen, Leo W J Klomp, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humansJohn S Millar, Margaret E Brousseau, Margaret R Diffenderfer, et al.
Journal of the American Heart Association|October 4, 2015
Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in WomenLeanne Hodson, Rajarshi Banerjee, Belén Rial, et al.
Pageof 15